IndiAge NeutraFlex
New Neutral cellulase granule for denim finishing
DESCRIPTION IndiAge NeutraFlex is a highly concentrated cellulase specifically designed to be formulated for use in premium, high-contrast denim finishing. IndiAge NeutraFlex allows the stonewashing process to take place in a wide range of pH and temperature conditions. This results in ease of use and ease of formulation. IndiAge NeutraFlex enzyme is granulated using the Enzoguard technology, featuring: Narrow particle size distribution. Chemical and physical stability. Good blendability. Genencor uses state-of-the-art biotechnology methods. This product contains an enzyme produced by a genetically modified organism, in a fermentation process and is biodegradable. ADVANTAGES IndiAge NeutraFlex has outstanding performance in low temperature and wide pH range, resulting in a robust performance. IndiAge NeutraFlex renders excellent storage stability even in high temperatures, reducing the loss of activity during storage. IndiAge NeutraFlex gives a high contrast effect with low backstaining level, producing high quality garments with ease of clean-up after stonewashing.
PROCESS CONDITIONS Proper and complete desizing prior to the stonewashing cycle is required for consistent performance. Genencor Optisize amylase products are recommended for removal of starch sizing materials. Low and high temperature amylase products are available from Genencor. pH and Temperature. To optimize enzyme performance for abrasion, backstaining, and fabric strength retention, use the parameters in the table shown below. Table 1. Operating parameters process parameter pH Temperature Liquor ratio Time operational range 5.0 - 8.0 20 - 60 C ( 68 - 140F) 3:1 to 20:1 15 - 60 minutes
DOSAGE RECOMMENDATIONS IndiAge NeutraFlex enzyme is a concentrated enzyme product; it is not designed to be used as ready-to-use product. The dosage of the final formulation depends on the type of formulation, as well as on the process parameters, the type of denim, the type of machine, and the desired effects. As a starting point, a range of 1 - 5 % in the formulation is recommended. ENZYME INACTIVATION If desired, IndiAgeI NeutraFlex enzyme can be inactivated by holding the bath at pH > 9.0 and temperature > 30C for 5 minutes. Soda ash (sodium carbonate) or borax (sodium borate) or an alkaline detergent are recommended for pH adjustment. PACKAGING IndiAge NeutraFlex enzyme is available in 20 kg carton boxes and 1000 kg big bags.
PRODUCT CHARACTERISTICS Activity: Min. 800 NPCN Units/g(*) Appearance: Spherical tan, free flowing granules
(*)The activity of the enzyme is expressed in NPCN (o-Nitrophenyl- -D-cellobioside neutral) units and is determined against an internal standard for ensuring lot-to-lot consistency. The enzyme activity value is not a measure for abrasion performance. A detailed assay method is available upon request.
FORMULATION IndiAge NeutraFlex enzyme is compatible with most textile processing aids, including buffers, nonionic wetting agents and dispersants, pumice stones, and diatomaceous earth. A Formulation Guideline is available upon request.
Together we can.
STORAGE To ensure extended shelf life, store IndiAge NeutraFlex enzyme at 25C or below in a closed plastic-liner within a sealed container. Prolonged exposure of this product to elevated temperature and/or humidity levels will result in a loss of activity. Reformulated IndiAge NeutraFlex products should also be packaged in closed plastic liners within sealed containers. SAFETY & ENZYME HANDLING Inhalation of enzyme dust and mists should be avoided. In case of contact with the skin or eyes, promptly rinse with water for at least 15 minutes. For detailed handling information, please refer to the appropriate Material Safety Data Sheet; the Enzyme Technical Association (ETA) handbook, Working Safely With Enzymes; and the Association of Manufacturers and Formulators of Enzyme Products (Amfep) handbook, Guide to the Safe Handling of Microbial Enzyme Preparations. All are available from Genencor.
CONTACT INFORMATION North America Rochester, New York t: +1 800 847 5311 f: +1 585 256 5295 Europe, Middle East & Africa Leiden, The Netherlands t: +31 71 5686 168 f: +31 71 5686 169 Latin America Buenos Aires, Argentina t: +54 11 4875 9500 f: +54 11 4875 9529 So Paulo, Brazil t: +55 11 4613 3800 f: +55 11 4612 1101 Asia/Pacific Singapore t: +65 6511 5600 f: +65 6511 5666 Shanghai, P.R. China t: +86 21 2307 9588 f: +86 21 2307 9599 Mumbai, India t: +91 22 30087131 f: +91 22 30087150 Lahore, Pakistan t: +92 300 8476 404 f: +92 42 35437 866
textiles@[Link] [Link].
2011 Danisco US Inc. Genencor, Enzoguard, IndiAge and Optisize are registered trademarks of Danisco US Inc. or its affiliates in the United States and/or other countries. Use and/or sale of this product may be covered by one or more patents in the U.S. and other countries as well as pending patents in the U.S. and other countries. The information contained in this product literature is, to the best of our knowledge, true and accurate and the product as sold is in conformance with the specifications set forth herein as determined by the assay methods described herein. Due to conditions of use, technical errors or omissions, improper handling or storage beyond our control, Danisco US Inc. hereby disclaims any express or implied warranties, including the implied warranties of merchantability or fitness for a particular purpose. Danisco US Inc. shall not be liable for any incidental, consequential, or special damages resulting in any way from the furnishing, performance, or use of this product literature or the product described herein. Nothing contained herein shall be construed as a representation by Danisco US Inc. that the use or resale of the product or processes described herein will not violate any rules or regulations of any countries, regions, localities, etc., or infringe upon patents or other intellectual property rights of third parties or that the recommendations and usage suggestions described constitute any authorization or inducement to infringe any such rights. This document is subject to change without further notice. REV 3220-01 PLH 14 March 11
[Link]
